Literature DB >> 2673766

Primary hyperparathyroidism. Clinical presentation and factors influencing clinical management.

D A Heath1.   

Abstract

Primary hyperparathyroidism becomes increasingly common with age and affects females four times more commonly than males. We now know that the majority of patients are asymptomatic of the disease and the commonest symptoms are fatigue and lethargy. Because of these facts, it is now appropriate to consider conservative management of primary hyperparathyroidism in the older patient who is asymptomatic or who has only mild symptoms. Further studies are indicated to ascertain whether such a conservative policy is correct.

Entities:  

Mesh:

Year:  1989        PMID: 2673766

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  10 in total

Review 1.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 2.  Primary hyperparathyroidism: a surgical perspective.

Authors:  M H Wheeler
Journal:  Ann R Coll Surg Engl       Date:  1998-09       Impact factor: 1.891

3.  Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.

Authors:  A C Hutchesson; N J Bundred; W A Ratcliffe
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

4.  Molecular classification of parathyroid neoplasia by gene expression profiling.

Authors:  Carl Morrison; William Farrar; Jeff Kneile; Nita Williams; Yiwen Liu-Stratton; Alan Bakaletz; Micheala A Aldred; Charis Eng
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 5.  Asymptomatic primary hyperparathyroidism.

Authors:  B J Harrison; M H Wheeler
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

6.  Does Primary Hyperparathyroidism Have an Association with Thyroid Papillary Cancer? A Retrospective Cohort Study.

Authors:  Kenan Çetin; Hasan E Sıkar; Şule Temizkan; Cem B Ofluoğlu; Ayşenur Özderya; Kadriye Aydın; Aylin E Gül; Hasan F Küçük
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

7.  Parathyroid adenomas with pronounced lymphocytic infiltration: no evidence of autoimmune pathogenesis.

Authors:  K Y Lam; A C Chan; C Y Lo
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

8.  Primary hyperparathyroidism in Austria: results of an 8-year prospective study.

Authors:  B Niederle; L Stamm; F Längle; E Schubert; W Woloszczuk; R Prager
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

9.  Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma.

Authors:  Jelena Maletkovic; Jennifer P Isorena; Miguel Fernando Palma Diaz; Stanley G Korenman; Michael W Yeh
Journal:  Case Rep Endocrinol       Date:  2014-03-05

10.  Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study.

Authors:  Chaiho Jeong; Hye In Kwon; Hansang Baek; Hun-Sung Kim; Dong-Jun Lim; Ki-Hyun Baek; Jeonghoon Ha; Moo Il Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2020-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.